1. CD34+ cell therapy is safe and effective in slowing the decline of hepatic reserve function in patients with decompensated liver cirrhosis. Issue 10 (October 2014) Authors: Nakamura, Toru; Torimura, Takuji; Iwamoto, Hideki; Kurogi, Jyunichi; Inoue, Hiroto; Hori, Yukie; Sumie, Shuji; Fukushima, Nobuyoshi; Sakata, Masahiro; Koga, Hironori; Abe, Mitsuhiko; Ikezono, Yu; Hashimoto, Osamu; Ueno, Takato; Oho, Kazuhiko; Okamura, Takashi; Okuda, Seiya; Kawamoto, Atsuhiko; Ii... Journal: Journal of gastroenterology and hepatology Issue: Volume 29:Issue 10(2014:Oct.) Page Start: 1830 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. High expression of CD44v9 and xCT in chemoresistant hepatocellular carcinoma: Potential targets by sulfasalazine. Issue 9 (16th August 2018) Authors: Wada, Fumitaka; Koga, Hironori; Akiba, Jun; Niizeki, Takashi; Iwamoto, Hideki; Ikezono, Yu; Nakamura, Toru; Abe, Mitsuhiko; Masuda, Atsutaka; Sakaue, Takahiko; Tanaka, Toshimitsu; Kakuma, Tatsuyuki; Yano, Hirohisa; Torimura, Takuji Journal: Cancer science Issue: Volume 109:Issue 9(2018) Page Start: 2801 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗